Skip to main content
Top

Current Treatment Options in Oncology

Issue 1/2020

Content (9 Articles)

Systemic Therapy Head and Neck Cancer (CP Rodriguez, Section Editor)

Multimodal Therapy for Sinonasal Malignancies: Updates and Review of Current Treatment

Mayur D. Mody, Nabil F. Saba

Lymphoma Leukemia (PH Wiernik, Section Editor)

Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy

Shaheedul A. Sami, Noureldien H. E. Darwish, Amanda N. M. Barile, Shaker A. Mousa

Acute Myeloid Leukemia Leukemia (PH Wiernik, Section Editor)

Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy

Sebastian Schwind, Madlen Jentzsch, Enrica Bach, Sebastian Stasik, Christian Thiede, Uwe Platzbecker

Probiotics Leukemia (PH Wiernik, Section Editor)

The Microbiota in Hematologic Malignancies

Yajing Song, Bryan Himmel, Lars Öhrmalm, Peter Gyarmati

Rectal Cancer Lower Gastrointestinal Cancers (AB Benson, Section Editor)

Locally Advanced Rectal Cancer: Treatment Approach in Elderly Patients

Francesca De Felice, Daniele Crocetti, Veronica Maiuri, Martina Parisi, Francesco Marampon, Luciano Izzo, Giorgio De Toma, Daniela Musio, Vincenzo Tombolini

Open Access Metastasis Lower Gastrointestinal Cancers (AB Benson, Section Editor)

Opioids in Cancer Development, Progression and Metastasis: Focus on Colorectal Cancer

Adrian Szczepaniak, Jakub Fichna, Marta Zielińska

Sarcopenia Palliative and Supportive Care (MP Davis, Section Editor)

Chemotherapy-Induced Sarcopenia

Federico Bozzetti

Open Access Care Palliative and Supportive Care (MP Davis, Section Editor)

Prognosticating for Adult Patients With Advanced Incurable Cancer: a Needed Oncologist Skill

Christina Chu, Rebecca Anderson, Nicola White, Patrick Stone

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine